Replacing high-cost generics with cheaper medications that have the same clinical benefit could have cut down spending and saved patients about 88%, according to Johns Hopkins research published in JAMA Network Open.

The use of generics is generally understood as a cost-saving practice, and insurers generally aim for high generic substitution rates as a cost-containment measure. But not all generics necessarily represent the lowest-cost option, researchers found.